62 related articles for article (PubMed ID: 38731049)
1. Multimodal PA/US imaging in Rheumatoid Arthritis: Enhanced correlation with clinical scores.
Huang Z; Liu D; Mo S; Hong X; Xie J; Chen Y; Liu L; Song D; Tang S; Wu H; Xu J; Dong F
Photoacoustics; 2024 Aug; 38():100615. PubMed ID: 38817689
[TBL] [Abstract][Full Text] [Related]
2. Level of glial cell derived neurotrophic factor in the blood plasma of rheumatoid arthritis patients and its relationship with alexithymia.
Shalkovskyi Y; Stanislavchuk M
Reumatologia; 2024; 62(2):94-100. PubMed ID: 38799779
[TBL] [Abstract][Full Text] [Related]
3. The effects of vitamin D supplementation on disease activity and fatigue in Libyan rheumatoid arthritis patients.
Elfituri S
Reumatologia; 2024; 62(2):109-114. PubMed ID: 38799782
[TBL] [Abstract][Full Text] [Related]
4. Predictors for severe persisting pain in rheumatoid arthritis are associated with pain origin and appraisal of pain.
Baerwald C; Stemmler E; Gnüchtel S; Jeromin K; Fritz B; Bernateck M; Adolf D; Taylor PC; Baron R
Ann Rheum Dis; 2024 May; ():. PubMed ID: 38816064
[TBL] [Abstract][Full Text] [Related]
5. Predictors of Remission or Combined Remission and Low Disease Activity in Rheumatoid Arthritis Patients in Taiwan: A Prospective Cohort Study.
Tsai PH; Fang YF; Chen YF; Chen CC; Chiang WY; Chang CT; Huang YJ; Liou LB
J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38731049
[No Abstract] [Full Text] [Related]
6. Inflammatory Biomarkers in the Diagnosis and Prognosis of Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Mena-Vázquez N; Godoy-Navarrete FJ; Lisbona-Montañez JM; Redondo-Rodriguez R; Manrique-Arija S; Rioja J; Mucientes A; Ruiz-Limón P; Garcia-Studer A; Ortiz-Márquez F; Oliver-Martos B; Cano-García L; Fernández-Nebro A
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047772
[TBL] [Abstract][Full Text] [Related]
7. Chemokines and chemokine receptors as promising targets in rheumatoid arthritis.
Murayama MA; Shimizu J; Miyabe C; Yudo K; Miyabe Y
Front Immunol; 2023; 14():1100869. PubMed ID: 36860872
[TBL] [Abstract][Full Text] [Related]
8. Increased Galectin-9 Levels Correlate with Disease Activity in Patients with DMARD-Naïve Rheumatoid Arthritis and Modulate the Secretion of MCP-1 and IL-6 from Synovial Fibroblasts.
Nielsen MA; Køster D; Mehta AY; Stengaard-Pedersen K; Busson P; Junker P; Hørslev-Petersen K; Hetland ML; Østergaard M; Hvid M; Leffler H; Kragstrup TW; Cummings RD; Deleuran B
Cells; 2023 Jan; 12(2):. PubMed ID: 36672263
[No Abstract] [Full Text] [Related]
9. Multibiomarker disease activity score: an objective tool for monitoring rheumatoid arthritis? A systematic review and meta-analysis.
Meznerics FA; Kemény LV; Gunther E; Bakó E; Dembrovszky F; Szabó B; Ascsillán A; Lutz E; Csupor D; Hegyi P; Bánvölgyi A; Nagy G
Rheumatology (Oxford); 2023 Jun; 62(6):2048-2059. PubMed ID: 36575983
[TBL] [Abstract][Full Text] [Related]
10. Predictors of remission in rheumatoid arthritis patients treated with biologics: a systematic review and meta-analysis.
Khader Y; Beran A; Ghazaleh S; Lee-Smith W; Altorok N
Clin Rheumatol; 2022 Dec; 41(12):3615-3627. PubMed ID: 35974226
[TBL] [Abstract][Full Text] [Related]
11. Serum 14-3-3η as predictor of clinical remission and progression of structural damage in early rheumatoid arthritis following a treat-to-target strategy in a randomized controlled trial.
Raft MB; Hetland ML; Brahe CH; Hørslev-Petersen K; Midtbøll Ørnbjerg L; Junker P; Biln N; Stengaard-Pedersen K; Østergaard M
Scand J Rheumatol; 2023 Jul; 52(4):342-352. PubMed ID: 35833274
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-17 as a predictor of subclinical synovitis in the remission state of rheumatoid arthritis.
Misra S; Mondal S; Chatterjee S; Dutta S; Sinha D; Bhattacharjee D; Lahiri D; Ghosh A
Cytokine; 2022 May; 153():155837. PubMed ID: 35255378
[TBL] [Abstract][Full Text] [Related]
13. Serum Reactive Oxygen Metabolites as a Predictor of Clinical Disease Activity Index, Simplified Disease Activity Index, and Boolean Remissions in Rheumatoid Arthritis Patients Treated With Biologic Agents.
Nakajima A; Terayama K; Sonobe M; Akatsu Y; Saito J; Norimoto M; Taniguchi S; Kubota A; Aoki Y; Nakagawa K
Cureus; 2021 Nov; 13(11):e19759. PubMed ID: 34938634
[TBL] [Abstract][Full Text] [Related]
14. Hematological parameters as a predictor of disease remission in patients with rheumatoid arthritis.
Dechanuwong P; Phuan-Udom R
Ann Med Surg (Lond); 2021 Dec; 72():103085. PubMed ID: 34868575
[TBL] [Abstract][Full Text] [Related]
15. Baseline predictors of remission, pain and fatigue in rheumatoid arthritis: the TITRATE trial.
Lee SY; Ibrahim F; Tom BDM; Nikiphorou E; Williams FMK; Lempp H; Scott DL
Arthritis Res Ther; 2021 Nov; 23(1):278. PubMed ID: 34736525
[TBL] [Abstract][Full Text] [Related]
16. Characterization of disease course and remission in early seropositive rheumatoid arthritis: results from the TACERA longitudinal cohort study.
RA-MAP Consortium
Ther Adv Musculoskelet Dis; 2021; 13():1759720X211043977. PubMed ID: 34707695
[TBL] [Abstract][Full Text] [Related]
17. Reverse expression of α2,6-sialic acid ratios on IgG, IgM, and IgG/IgM autoantibodies correlates with mouse arthritis and rheumatoid arthritis disease activity.
Liou LB; Huang CC
J Chin Med Assoc; 2020 Dec; 83(12):1079-1086. PubMed ID: 33009208
[TBL] [Abstract][Full Text] [Related]
18. Predictors of joint damage progression and stringent remission in patients with established rheumatoid arthritis in clinical remission.
Møller-Bisgaard S; Georgiadis S; Hørslev-Petersen K; Ejbjerg B; Hetland ML; Ørnbjerg LM; Glinatsi D; Møller J; Boesen M; Stengaard-Pedersen K; Madsen OR; Jensen B; Villadsen JA; Hauge EM; Bennett P; Hendricks O; Asmussen K; Kowalski M; Lindegaard H; Bliddal H; Krogh NS; Ellingsen T; Nielsen AH; Balding L; Jurik AG; Thomsen HS; Østergaard M
Rheumatology (Oxford); 2021 Jan; 60(1):380-391. PubMed ID: 32929463
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
